Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Sevoflurane vs Propofol for Cognitive Function in Open-Heart Surgery
NCT00541918Phase 4Withdrawn
- Sponsor
- Medical University of Gdańsk
- Start
- Jun 2007
- Primary completion
- Apr 2015
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised, open-label trial of sevoflurane in valvular heart disease (VHD) (2 arms), sponsored by Medical University of Gdańsk. Primary endpoint: Results of psychological examination at 12 months. Planned start Jun 2007; status: withdrawn.
02
Drugs
sevoflurane
03
Conditions
valvular heart disease (VHD)
Beyond the preview
Go deeper on NCT00541918.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00541918.